Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
Holders of 5% or more of AUPH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aurinia Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Tang Capital Management LLC | 13D/A | 10.00%13.0M shares | +0.80 ppfrom 9.20% | Mar 4, 20254 filings | Jun 4, 2026 | SEC |
| ILJIN SNT Co., Ltd. | 13D/A | 5.00%6.54M shares | – | Aug 13, 20251 filing | Aug 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Aurinia Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 4, 20266:44 PM ET | Tang Capital Management LLCand 5 others | 13D/A | 10.00%13.0M shares | +0.80 ppfrom 9.20% | Jun 2, 2026 | SEC |
| Mar 25, 20264:15 PM ET | Tang Capital Management LLCand 5 others | 13D/A | 9.20%12.2M shares | 0.00 ppfrom 9.20% | Mar 23, 2026 | SEC |
| Mar 3, 20265:30 PM ET | Tang Capital Management LLCand 5 others | 13D/A | 9.20%12.2M shares | +1.90 ppfrom 7.30% | Feb 27, 2026 | SEC |
| Aug 13, 20259:40 PM ET | ILJIN SNT Co., Ltd.and 5 others | 13D/A | 5.00%6.54M shares | – | Aug 11, 2025 | SEC |
| Mar 4, 20255:04 PM ET | Tang Capital Management LLCand 5 others | 13D/A | 7.30%10.0M shares | – | Feb 28, 2025 | SEC |
| Feb 14, 20255:05 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.47%6.40M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aurinia Pharmaceuticals Inc. shares.
No Form 144 notices for Aurinia Pharmaceuticals Inc. are on file.